Anti-CLEC12A antibodies are used in the immunodetection of the protein C-type lectin domain family 12 member A. In humans, the canonical protein has a reported length of 265 amino acid residues and a mass of 30.8 kDa. Its subcellular localization is in the cell membrane. Up to 5 different isoforms have been reported for this protein. It is notably expressed in normal myeloid cells and in acute myeloid leukemia cells. CLEC12A is a reported cell surface receptor that modulates signaling cascades and mediates tyrosine phosphorylation of target MAP kinases. Post-translational modifications have been described, including N-glycosylation. Synonyms for this target antigen include C-type lectin-like molecule-1, dendritic cell-associated lectin 2, myeloid inhibitory C-type lectin-like receptor, and C-type lectin protein CLL-1. CLEC12A gene orthologs have been reported in the mouse, rat, bovine and chimpanzee species. Over 110 citations in the literature describe the use of CLEC12A antibodies in research. These antibodies are most commonly used in Flow Cytometry experiments, among other applications.